Tsunehiro Oyama Selected Research

Tsunehiro Oyama Research Topics

Disease

33	Neoplasms (Cancer) 04/2021 - 01/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2002
16	Lung Neoplasms (Lung Cancer) 04/2021 - 12/2002
6	Esophageal Squamous Cell Carcinoma 09/2015 - 07/2007
6	Neoplasm Metastasis (Metastasis) 05/2011 - 06/2002
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010 - 09/2005
5	Adenocarcinoma of Lung 04/2011 - 07/2007
4	Esophageal Neoplasms (Esophageal Cancer) 05/2012 - 09/2005
4	Adenocarcinoma 01/2009 - 09/2005
3	Neoplasm Micrometastasis 12/2010 - 01/2002
3	Carcinoma (Carcinomatosis) 05/2006 - 04/2003
2	Carcinogenesis 12/2010 - 05/2006
2	Lymphatic Metastasis 08/2009 - 05/2009
2	Liver Diseases (Liver Disease) 01/2009 - 09/2007
2	Body Weight (Weight, Body) 12/2007 - 02/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2016
1	Metabolic Bone Diseases (Osteopenia) 05/2011
1	Colonic Neoplasms (Colon Cancer) 04/2011
1	Weight Loss (Weight Reduction) 11/2009
1	Hepatitis 01/2009
1	Ductal Carcinoma 01/2007
1	Scirrhous Adenocarcinoma (Scirrhous Carcinoma) 01/2007
1	Hemorrhage 01/2007
1	Large Cell Carcinoma 09/2005
1	Breast Neoplasms (Breast Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 05/2011 - 01/2002
8	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2012 - 03/2003
7	Ethanol (Ethyl Alcohol)IBA 09/2015 - 01/2005
7	ErbB Receptors (EGF Receptor)IBA 05/2010 - 01/2006
6	ParaffinIBA 12/2010 - 10/2004
5	AcetaldehydeIBA 09/2015 - 01/2007
4	CarcinogensIBA 09/2015 - 03/2003
4	Aldehyde DehydrogenaseIBA 01/2014 - 09/2005
4	Estrogens (Estrogen)FDA Link 01/2012 - 07/2007
4	Biological ProductsIBA 08/2009 - 03/2005
4	Gefitinib (Iressa)FDA Link 06/2009 - 01/2006
4	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2007 - 12/2002
3	Aromatase (CYP19)IBA 01/2012 - 05/2008
3	Messenger RNA (mRNA)IBA 04/2011 - 12/2007
3	DNA AdductsIBA 12/2010 - 05/2007
3	EnzymesIBA 05/2008 - 02/2002
3	CytochromesIBA 05/2007 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2010 - 01/2009
2	Indicators and Reagents (Reagents)IBA 05/2009 - 10/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009 - 01/2006
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2007 - 01/2007
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2007 - 03/2003
2	Cytochrome P-450 CYP3AIBA 01/2007 - 05/2005
2	Histidine (L-Histidine)FDA Link 05/2006 - 05/2006
2	Tumor Biomarkers (Tumor Markers)IBA 03/2005 - 01/2003
2	Keratins (Keratin)IBA 07/2002 - 01/2002
1	AldehydesIBA 01/2022
1	A 17 (A-17)IBA 04/2021
1	naftopidilIBA 04/2016
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 04/2016
1	Anticarcinogenic AgentsIBA 01/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2011
1	Fluorouracil (Carac)FDA LinkGeneric 01/2011
1	Thymidylate SynthaseIBA 01/2011
1	Vascular Endothelial Growth Factor CIBA 12/2010
1	Cadherins (E-Cadherin)IBA 12/2010
1	gamma Catenin (Plakoglobin)IBA 12/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010
1	alpha Catenin (alpha E-Catenin)IBA 12/2010
1	beta CateninIBA 12/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2010
1	DeoxyguanosineIBA 01/2010
1	CateninsIBA 05/2009
1	Estrogen ReceptorsIBA 01/2009
1	Estrogen Receptor betaIBA 01/2009
1	Hormones (Hormone)IBA 01/2009
1	Alanine Transaminase (SGPT)IBA 01/2009
1	Aromatase InhibitorsIBA 01/2009
1	SolventsIBA 01/2009
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2009
1	AndrogensIBA 01/2009
1	Vitamin D3 24-HydroxylaseIBA 05/2008
1	Estrogen Receptor alphaIBA 07/2007
1	Gonadal Steroid Hormones (Sex Hormones)IBA 07/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2007
1	Pharmaceutical PreparationsIBA 01/2007
1	ProdrugsIBA 01/2007
1	Tyrosine Kinase InhibitorsIBA 12/2006
1	Methionine (L-Methionine)FDA Link 12/2006
1	Threonine (L-Threonine)FDA Link 12/2006
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2006
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 03/2006
1	Protein Kinases (Protein Kinase)IBA 01/2006
1	involucrinIBA 01/2006
1	Adenosine Triphosphate (ATP)IBA 01/2006
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2005
1	Endoplasmic Reticulum Chaperone BiPIBA 07/2005
1	Tamoxifen FDA LinkGeneric 05/2005
1	Carcinoembryonic AntigenIBA 03/2005

Therapy/Procedure

4	Therapeutics 01/2012 - 06/2002
1	Oral Administration 04/2016
1	Chemoradiotherapy 01/2011